Scalable nanoprecipitation of niclosamide and in vivo demonstration of long-acting delivery after intramuscular injection†
Abstract
The control of COVID-19 across the world requires the formation of a range of interventions including vaccines to elicit an immune response and immunomodulatory or antiviral therapeutics. Here, we demonstrate the nanoparticle formulation of a highly insoluble drug compound, niclosamide, with known anti SARS-CoV-2 activity as a cheap and scalable long-acting injectable antiviral candidate.
- This article is part of the themed collection: Nanoscale Most Popular 2021 Articles